Charles River Laboratories (CRL): Director sold, ~$16.9M

~$16.9M
Approx. value · 75K sh @ $225.00: 32K
Holds after · shares reported

Traded: Jun 29, 2026
Filed: Jul 1, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Feb 25, 2026Federal contract · $936K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $936K obligated to date
Feb 28, 2026Federal contract · $5.3M obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $5.31M obligated to date
May 5, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 5, 2026, Charles River Laboratories International, Inc. (the “Company”) held its 2026 annual meeting of shareholders (the “Annual Meeting”). As further discussed below, at the Annual Meeting, the shareholders of the Company approved the Company’s 2026 Long-Term Incentive Plan (the “2026 Incentive Plan”).”
May 6, 20265% stakeFMR LLC reported a passive stake (13G) of 7.0%
May 6, 20265% stakeInvesco Ltd. reported a passive stake (13G) of 4.9%
May 7, 2026Company filing · Form 8-K · ResultsReported its results
Jun 1, 2026Federal contract · $340K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $340K obligated to date
Jun 1, 2026Federal contract · $340K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $340K obligated to date
Jun 29, 2026 · this disclosureInsider · Their largest sale since 2006Director sold ~$16.9M of CRL shares in the open market

What came next

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Charles River Laboratories

For Charles River Laboratories, OQRO holds 19 insider filings (SEC Form 4 or Form 144), 11 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRL page.

Other recent filings by James C Foster, Director

The full history of James C Foster, Director is on the profile page.

Other disclosures at Charles River Laboratories

Everything OQRO holds on this company is on its CRL page.

Charles River Laboratories (CRL)Director sold ~$16.9M